Medical devices, healthcare technology and the business of care
510(k) clearance · K263076

AngioVac F1885

AngioDynamics, Inc. · Decision date Oct 30, 2026

MEDTECHLEDGER EXPLANATIONK263076

What did the FDA decide?

The FDA's device database records K263076 for the AngioVac F1885, submitted by AngioDynamics, Inc. of Queensbury, New York. The entry lists the review specialty as cardiovascular and the product code as DWF, with a decision date of 30 October 2026 and a decision code of SESE. The record also shows a traditional review track, no third-party review, and a summary as the review advisory committee statement type. The source does not describe the specific component, modification, or intended change associated with this submission.

SESE denotes a 510(k) substantial-equivalence clearance rather than premarket approval of a new device. The record does not identify a predicate device, so the application relationship to prior cleared devices remains unknown. The listed title, AngioVac F1885, is the only device descriptor available here; indications, materials, and performance data are not included. Researchers should treat this as a clearance record only and consult the corresponding FDA 510(k) documents for scope and any clinical claims.

The source data are limited to a summary listing row, and no statement text was provided. Missing items include the device description, the changed or added component, and any comparison to a predicate. No efficacy, safety, or patient-selection conclusions can be drawn from this record.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Oct 30, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K263076
Regulatory pathway
510(k) premarket notification
Product code
DWF
Decision code
SESE
Decision date
Oct 30, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass.

Product code
DWF
FDA device class
2

FDA decision timeline

  1. K263076 received

    Application receipt date recorded by FDA.

  2. K263076 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code DWF

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic, Inc.510(k) clearanceOct 29, 2026FDA
Sorin Group Italia S.R.L.510(k) clearanceOct 1, 2026FDA
Sorin Group Italia S.R.L.510(k) clearanceSep 28, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

AngioDynamics, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Queensbury, NY

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records